1 of 3
Trump's Tariff Threat
- A new 15% tariff on European-branded medicines may raise costs for patients using GLP-1 drugs like Ozempic.
- The US-EU trade agreement, finalized on August 21, 2025, aims to strengthen supply chains and economic security.
- President Trump threatened additional tariffs on countries with perceived discriminatory digital regulations, risking US-EU relations.
- EU Commission President Ursula von der Leyen highlighted the deal's significance in preventing a trade war.
1 / 3
